Erlotinib EP Impurity M | CAS 183322-21-6 - Request Quote
Erlotinib EP Impurity M
| SZ CAT No: | SZ-E018069 |
| CAS No | 183322-21-6 |
| Mol.F. | C12H11Cl3N2O2 |
| Mol.Wt. | 321.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Erlotinib EP Impurity M is chemically 4-Chloro-6,7-bis(2-chloroethoxy)quinazoline (as per EP). Erlotinib EP Impurity M is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib EP Impurity M can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 183322-21-6
Purchase 183322-21-6
Order 183322-21-6
Enquire 183322-21-6
price of 183322-21-6
183322-21-6 Supplier
183322-21-6 Manufacturer
183322-21-6 Exporter
buy high quality Erlotinib EP Impurity M
Purchase Erlotinib EP Impurity M
Erlotinib EP Impurity M suppliers
Erlotinib EP Impurity M manufacturers
Erlotinib EP Impurity M price
Order Erlotinib EP Impurity M
Enquire Erlotinib EP Impurity M
Erlotinib EP Impurity M cost
Erlotinib EP Impurity M Supplier
Erlotinib EP Impurity M Distributor
Erlotinib EP Impurity M for Method Validation
Erlotinib Reference Standard
Erlotinib EP Impurity M for ANDA Filing
Erlotinib EP Impurity M for Forced Degradation Studies
Erlotinib EP Impurity M Identification Standards
Erlotinib EP Impurity M for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


